Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:328-341
doi: 10.1161/01.RES.0000256090.42690.05
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Towler, M. C.
Right arrow Articles by Hardie, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Towler, M. C.
Right arrow Articles by Hardie, D. G.
Related Collections
Right arrow Obesity
Right arrow Type 2 diabetes
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Cell signalling/signal transduction
Right arrow Energy metabolism
Right arrow Gene expression
Right arrow Gene regulation
(Circulation Research. 2007;100:328.)
© 2007 American Heart Association, Inc.


Reviews

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

Mhairi C. Towler, D. Grahame Hardie

From the Division of Molecular Physiology, College of Life Sciences, University of Dundee, Scotland, UK.

Correspondence to Prof D. G. Hardie, Division of Molecular Physiology, College of Life Sciences, University of Dundee, Sir James Black Centre, Dow St, Dundee, DD1 5EH, Scotland, UK. E-mail d.g.hardie{at}dundee.ac.uk

This Review is part of a thematic series on AMP Kinase, which includes the following articles:

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

Cardiac AMP-Activated Protein Kinase in Health and Disease
Bruce Kemp Guest Editor

The AMP-activated protein kinase (AMPK) system acts as a sensor of cellular energy status that is conserved in all eukaryotic cells. It is activated by increases in the cellular AMP:ATP ratio caused by metabolic stresses that either interfere with ATP production (eg, deprivation for glucose or oxygen) or that accelerate ATP consumption (eg, muscle contraction). Activation in response to increases in AMP involves phosphorylation by an upstream kinase, the tumor suppressor LKB1. In certain cells (eg, neurones, endothelial cells, and lymphocytes), AMPK can also be activated by a Ca2+-dependent and AMP-independent process involving phosphorylation by an alternate upstream kinase, CaMKKß. Once activated, AMPK switches on catabolic pathways that generate ATP, while switching off ATP-consuming processes such as biosynthesis and cell growth and proliferation. The AMPK complex contains 3 subunits, with the {alpha} subunit being catalytic, the ß subunit containing a glycogen-sensing domain, and the {gamma} subunits containing 2 regulatory sites that bind the activating and inhibitory nucleotides AMP and ATP. Although it may have evolved to respond to metabolic stress at the cellular level, hormones and cytokines such as insulin, leptin, and adiponectin can interact with the system, and it now appears to play a key role in maintaining energy balance at the whole body level. The AMPK system may be partly responsible for the health benefits of exercise and is the target for the antidiabetic drug metformin. It is a key player in the development of new treatments for obesity, type 2 diabetes, and the metabolic syndrome.


Key Words: calcium signaling • diabetes • insulin • metabolism • signaling pathways




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
G. Marino, A. P. Ugalde, N. Salvador-Montoliu, I. Varela, P. M. Quiros, J. Cadinanos, I. van der Pluijm, J. M.P. Freije, and C. Lopez-Otin
Premature aging in mice activates a systemic metabolic response involving autophagy induction
Hum. Mol. Genet., July 15, 2008; 17(14): 2196 - 2211.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Bertrand, S. Horman, C. Beauloye, and J.-L. Vanoverschelde
Insulin signalling in the heart
Cardiovasc Res, July 15, 2008; 79(2): 238 - 248.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. W. Schwenk, J. J.F.P. Luiken, A. Bonen, and J. F.C. Glatz
Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease
Cardiovasc Res, July 15, 2008; 79(2): 249 - 258.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Lee, J. S. Cho, N. Lambacher, J. Lee, S.-J. Lee, T. H. Lee, A. Gartner, and H.-S. Koo
The Caenorhabditis elegans AMP-activated Protein Kinase AAK-2 Is Phosphorylated by LKB1 and Is Required for Resistance to Oxidative Stress and for Normal Motility and Foraging Behavior
J. Biol. Chem., May 30, 2008; 283(22): 14988 - 14993.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Nahle, M. Hsieh, T. Pietka, C. T. Coburn, P. A. Grimaldi, M. Q. Zhang, D. Das, and N. A. Abumrad
CD36-dependent Regulation of Muscle FoxO1 and PDK4 in the PPAR{delta}/{beta}-mediated Adaptation to Metabolic Stress
J. Biol. Chem., May 23, 2008; 283(21): 14317 - 14326.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. D. Cheung and G. W. Hart
AMP-activated Protein Kinase and p38 MAPK Activate O-GlcNAcylation of Neuronal Proteins during Glucose Deprivation
J. Biol. Chem., May 9, 2008; 283(19): 13009 - 13020.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Ramachandran, G. Yu, and T. Gulick
Nuclear Respiratory Factor 1 Controls Myocyte Enhancer Factor 2A Transcription to Provide a Mechanism for Coordinate Expression of Respiratory Chain Subunits
J. Biol. Chem., May 2, 2008; 283(18): 11935 - 11946.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Fujita, N. Maeda, M. Sonoda, K. Ohashi, T. Hibuse, H. Nishizawa, M. Nishida, A. Hiuge, A. Kurata, S. Kihara, et al.
Adiponectin Protects Against Angiotensin II-Induced Cardiac Fibrosis Through Activation of PPAR-{alpha}
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 863 - 870.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Chavez, W. G. Roach, S. R. Keller, W. S. Lane, and G. E. Lienhard
Inhibition of GLUT4 Translocation by Tbc1d1, a Rab GTPase-activating Protein Abundant in Skeletal Muscle, Is Partially Relieved by AMP-activated Protein Kinase Activation
J. Biol. Chem., April 4, 2008; 283(14): 9187 - 9195.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. L. McGee, B. J.W. van Denderen, K. F. Howlett, J. Mollica, J. D. Schertzer, B. E. Kemp, and M. Hargreaves
AMP-Activated Protein Kinase Regulates GLUT4 Transcription by Phosphorylating Histone Deacetylase 5
Diabetes, April 1, 2008; 57(4): 860 - 867.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
X. Yang, C. Yang, A. Farberman, T. C. Rideout, C. F. M. de Lange, J. France, and M. Z. Fan
The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth
J Anim Sci, April 1, 2008; 86(14_suppl): E36 - E50.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. L. McGee, K. J. Mustard, D. G. Hardie, and K. Baar
Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase {alpha}1 following overload in LKB1 knockout mice
J. Physiol., March 15, 2008; 586(6): 1731 - 1741.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Lu, Q. Tang, J. M. Olefsky, P. L. Mellon, and N. J. G. Webster
Adiponectin Activates Adenosine Monophosphate-Activated Protein Kinase and Decreases Luteinizing Hormone Secretion in L{beta}T2 Gonadotropes
Mol. Endocrinol., March 1, 2008; 22(3): 760 - 771.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. F. Chehab
Minireview: Obesity and LipOdystrophy--Where Do the Circles Intersect?
Endocrinology, March 1, 2008; 149(3): 925 - 934.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. E. Osler and J. R. Zierath
Minireview: Adenosine 5'-Monophosphate-Activated Protein Kinase Regulation of Fatty Acid Oxidation in Skeletal Muscle
Endocrinology, March 1, 2008; 149(3): 935 - 941.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Miyamoto, N. Oshiro, K.-i. Yoshino, A. Nakashima, S. Eguchi, M. Takahashi, Y. Ono, U. Kikkawa, and K. Yonezawa
AMP-activated Protein Kinase Phosphorylates Golgi-specific Brefeldin A Resistance Factor 1 at Thr1337 to Induce Disassembly of Golgi Apparatus
J. Biol. Chem., February 15, 2008; 283(7): 4430 - 4438.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. H. Young
AMP-Activated Protein Kinase Conducts the Ischemic Stress Response Orchestra
Circulation, February 12, 2008; 117(6): 832 - 840.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. M. Thomson, S. T. Herway, N. Fillmore, H. Kim, J. D. Brown, J. R. Barrow, and W. W. Winder
AMP-activated protein kinase phosphorylates transcription factors of the CREB family
J Appl Physiol, February 1, 2008; 104(2): 429 - 438.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Dobrzyn, H. Sampath, A. Dobrzyn, M. Miyazaki, and J. M. Ntambi
Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart
Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E357 - E364.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W.-J. Zhang, K. E. Bird, T. S. McMillen, R. C. LeBoeuf, T. M. Hagen, and B. Frei
Dietary {alpha}-Lipoic Acid Supplementation Inhibits Atherosclerotic Lesion Development in Apolipoprotein E Deficient and Apolipoprotein E/Low-Density Lipoprotein Receptor Deficient Mice
Circulation, January 22, 2008; 117(3): 421 - 428.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
E. G. Beale
5'-AMP-Activated Protein Kinase Signaling in Caenorhabditis elegans
Experimental Biology and Medicine, January 1, 2008; 233(1): 12 - 20.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Zheng, A. Perianayagam, D. H. Lee, M. D. Brannan, L. E. Yang, D. Tellalian, P. Chen, K. Lemieux, A. Marette, J. H. Youn, et al.
AMPK activation with AICAR provokes an acute fall in plasma [K+]
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C126 - C135.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S. A Harrison and C. P. Day
Benefits of lifestyle modification in NAFLD
Gut, December 1, 2007; 56(12): 1760 - 1769.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. M. Thomson, J. D. Brown, N. Fillmore, B. M. Condon, H-J. Kim, J. R. Barrow, and W. W. Winder
LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1572 - E1579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Kodiha, J. G. Rassi, C. M. Brown, and U. Stochaj
Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK->ERK1/2 pathway
Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1427 - C1436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. F. Collins, H.-Y. Liu, J. Pi, Z. Liu, M. J. Quon, and W. Cao
Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5'-AMP-activated Protein Kinase
J. Biol. Chem., October 12, 2007; 282(41): 30143 - 30149.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
C. T. TAYLOR and J. POUYSSEGUR
Oxygen, Hypoxia, and Stress
Ann. N.Y. Acad. Sci., October 1, 2007; 1113(1): 87 - 94.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Li, M. Naples, H. Song, R. Yuan, F. Ye, S. Shafi, K. Adeli, and D. S. Ng
LCAT-null mice develop improved hepatic insulin sensitivity through altered regulation of transcription factors and suppressors of cytokine signaling
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E587 - E594.
[Abstract] [Full Text] [PDF]